Table 3 Clinical and anatomical characteristics of patients with cerebral embolism, by therapeutic strategy
Treatment | p-value | |||
|---|---|---|---|---|
Excluded from surgery (N = 20) | Surgery (N = 102) | No indication for surgery (N = 4) | ||
Age (years, median ± IQR) | 73 (66–79) | 66 (62–72) | 67 (36–78) | NS |
Dysability at admission (N, %) | ||||
Mild | 4 (21,1%) | 56 (62,9%) | 3 (75%) | 0.001 |
Moderate | 1 (5,3%) | 16 (18,0%) | 0 (0%) | |
Severe | 14 (73,7%) | 17 (19,1%) | 1 (25%) | |
Neurologic symptoms (N, %) | 18 (90,0%) | 69 (75,0%) | 2 (50%) | NS |
Heamorrhagic cerebral lesions (N, %) | 9 (45,0%) | 25 (24,5%) | 0 (0%) | NS |
Site of cerebral lesion (N, %) | ||||
Basal nuclei | 1 (5,3%) | 4 (4,3%) | 1 (25%) | NS |
Cerebral lobes | 12 (63,2%) | 61 (65,6%) | 2 (50%) | |
Cerebellum | 0 (0,0%) | 3 (3,2%) | 0 (0%) | |
Multiple sites | 6 (31,6%) | 25 (26,9%) | 1 (25%) | |